Titre : Tabac pour pipe à eau

Tabac pour pipe à eau : Questions médicales fréquentes

Termes MeSH sélectionnés :

Paranoid Disorders

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une dépendance au tabac à pipe à eau ?

Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage.
Dépendance au tabac Diagnostic médical
#2

Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?

Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé.
Fonction pulmonaire Tests diagnostiques

Symptômes 2

#1

Quels sont les symptômes d'une consommation excessive ?

Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires.
Toux Essoufflement
#2

Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?

Il peut causer des maladies des gencives, des caries et des taches sur les dents.
Santé bucco-dentaire Maladies des gencives

Prévention 2

#1

Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?

L'éducation sur les risques et la promotion d'activités alternatives sont essentielles.
Prévention du tabagisme Éducation à la santé
#2

Quelles campagnes sont efficaces contre le tabac à pipe à eau ?

Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs.
Campagnes de santé publique Tabagisme

Traitements 2

#1

Quels traitements existent pour arrêter le tabac à pipe à eau ?

Les traitements incluent les thérapies comportementales et les substituts nicotiniques.
Thérapie comportementale Substituts nicotiniques
#2

Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?

Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer.
Varénicline Médicaments anti-tabac

Complications 2

#1

Quelles sont les complications respiratoires liées au tabac à pipe à eau ?

Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon.
Bronchite chronique Cancer du poumon
#2

Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?

Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine.
Maladies cardiovasculaires Circulation sanguine

Facteurs de risque 2

#1

Quels sont les principaux facteurs de risque du tabac à pipe à eau ?

Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs.
Facteurs de risque Tabagisme
#2

Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?

Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse.
Grossesse Tabagisme
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes", "headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-02-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Produits du tabac", "url": "https://questionsmedicales.fr/mesh/D062789", "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844" } } }, "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Omar F Khabour", "url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour", "affiliation": { "@type": "Organization", "name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Karem H Alzoubi", "url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Erin L Sutfin", "url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin", "affiliation": { "@type": "Organization", "name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu." } }, { "@type": "Person", "name": "Jennifer Cornacchione Ross", "url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross", "affiliation": { "@type": "Organization", "name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA." } }, { "@type": "Person", "name": "Thomas Eissenberg", "url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Paranoid thinking and perceived competitive intention.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36923500", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.15003" } }, { "@type": "ScholarlyArticle", "name": "Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.", "datePublished": "2023-05-27", "url": "https://questionsmedicales.fr/article/37307645", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbtep.2023.101884" } }, { "@type": "ScholarlyArticle", "name": "Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.", "datePublished": "2022-08-15", "url": "https://questionsmedicales.fr/article/35971137", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06614-0" } }, { "@type": "ScholarlyArticle", "name": "Experimental studies of paranoid thinking in clinical and nonclinical populations: a systematic review and meta-analysis.", "datePublished": "2023-07-10", "url": "https://questionsmedicales.fr/article/37427557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S0033291723001708" } }, { "@type": "ScholarlyArticle", "name": "A randomised controlled test in virtual reality of the effects on paranoid thoughts of virtual humans' facial animation and expression.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39048648", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67534-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" }, { "@type": "ListItem", "position": 6, "name": "Tabac pour pipe à eau", "item": "https://questionsmedicales.fr/mesh/D000073846" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tabac pour pipe à eau - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tabac pour pipe à eau", "description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tabac pour pipe à eau", "description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tabac pour pipe à eau", "description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tabac pour pipe à eau", "description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tabac pour pipe à eau", "description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tabac pour pipe à eau", "description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Paranoid+Disorders#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une consommation excessive ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires." } }, { "@type": "Question", "name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents." } }, { "@type": "Question", "name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles." } }, { "@type": "Question", "name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer." } }, { "@type": "Question", "name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon." } }, { "@type": "Question", "name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 14/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Omar F Khabour

8 publications dans cette catégorie

Affiliations :
  • Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.

Karem H Alzoubi

8 publications dans cette catégorie

Affiliations :
  • Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Erin L Sutfin

7 publications dans cette catégorie

Affiliations :
  • Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu.

Jennifer Cornacchione Ross

7 publications dans cette catégorie

Affiliations :
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Boston University School of Public Health, Boston, Massachusetts, USA.

Thomas Eissenberg

7 publications dans cette catégorie

Affiliations :
  • Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America.
Publications dans "Tabac pour pipe à eau" : Voir toutes les publications (7)

Rima Nakkash

6 publications dans cette catégorie

Affiliations :
  • Department of Health Promotion and Community Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
  • Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, VA, United States.

Ramzi G Salloum

5 publications dans cette catégorie

Affiliations :
  • Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, FL, United States.

Mohammed Jawad

5 publications dans cette catégorie

Affiliations :
  • Public Health Policy Evaluation Unit, Imperial College London, Hammersmith, UK.

Ngoan Tran Le

4 publications dans cette catégorie

Affiliations :
  • Institute of Research and Development, Duy Tan University, Da Nang City, Vietnam.
  • Department of Occupational Health, Institute for Preventive Medicine and Public Health, Hanoi Medical University, Ha Noi City, Vietnam.
  • Center for Health Promotion and Research, Hanoi Prospective Cohort Study, Hanoi City, Vietnam.

Can Van Phan

4 publications dans cette catégorie

Affiliations :
  • Center for Health Promotion and Research, Hanoi Prospective Cohort Study, Hanoi City, Vietnam.
  • Center for Population Health Sciences, Hanoi University of Public Health, Ha Noi City, Vietnam.

Phuoc Hong Le

4 publications dans cette catégorie

Affiliations :
  • Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Noura O Kassem

4 publications dans cette catégorie

Affiliations :
  • San Diego State University Research Foundation, San Diego, California, USA.

Allison J Lazard

4 publications dans cette catégorie

Affiliations :
  • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Hussman School of Media and Journalism, University of North Carolina, Chapel Hill, North Carolina, USA.
Publications dans "Tabac pour pipe à eau" :

Brittney Keller-Hamilton

4 publications dans cette catégorie

Affiliations :
  • Mohammed Moumen, Medical Student, Wake Forrest School of Medicine, Winston-Salem, NC. Marielle Brinkman, Senior Research Scientist, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Brittney Keller-Hamilton, Research Scientist, Comprehensive Cancer Center, The Ohio State University, Columbus, OH. Andreas A. Teferra, Doctoral Student, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Megan E. Roberts, Assistant Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Elizabeth G. Klein, Interim Chair and Associate Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Paul Nini, Professor, Department of Design, College of Arts and Sciences, The Ohio State University, Columbus, OH. Michael Pennell, Associate Professor, Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH. Amy K. Ferketich, Professor Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH.

Theodore L Wagener

4 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.

Darren Mays

4 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.

Kenneth D Ward

4 publications dans cette catégorie

Affiliations :
  • Division of Social and Behavioral Science, School of Public Health, University of Memphis, Memphis, TN.

Mohammad Ebrahimi Kalan

4 publications dans cette catégorie

Affiliations :
  • Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA.

Sources (10000 au total)

Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.

Cognitive theories assume an imbalance of intuitive and analytical reasoning in paranoid ideation. The argumentative theory of reasoning offers an approach on the primary function of reasoning and its... 327 participants completed the Social Network Index (SNI), the Paranoia Checklist (PCL), and the Cognitive Reflection Test-2 (CRT2). Moreover, preference and frequency of discussions were assessed. In... The discussion group showed lower distorted reflective reasoning than the control group. Discussion preference and/or frequency was associated with frequency and disturbance of paranoid thoughts, as w... Due to the online format environmental factors could not be held constant and no intrasubject comparison of the CRT2 could be computed in the trial. Furthermore, the sample mainly consisted of psychol... The results contribute to the understanding of distorted reflective reasoning and provides preliminary evidence that the argumentative theory of reasoning may offer a promising perspective for delusio...

Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.

Schizophrenia spectrum disorders cause suffering for patients, relatives, and the surrounding society. Paranoid ideations, encompassing ideas of social reference and manifest persecutory delusions, ar... This study is a randomized, assessor-blinded parallel-groups multi-center superiority clinical trial, fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients diagnos... The trial will elucidate whether VR-CBT can enhance therapy efficacy for paranoid ideations. Additionally, Trial findings will provide evidence on the effectiveness and cost-effectiveness of VR-CBT fo... ClinicalTrials.gov NCT04902066 . Initial release April 9th, 2021....

"Green et al. Paranoid Thoughts Scale-revised": Structural invariance and clinical utility of a brief version in schizophrenia.

Persecutory ideas are highly frequent in psychotic disorders and particularly in schizophrenia. Although several measures exist to assess persecutory ideas in both clinical and non-clinical samples, t... 100 individuals with schizophrenia and 72 non-clinical controls were recruited. We used the GPTS-8, a brief 8-item version of the R-GPTS recently developed and validated in the French general populati... Confirmatory factor analysis supported the original two-factor structure (social reference and persecution subscales) of the GPTS-8. The GPTS-8 was positively and moderately correlated with the Positi... The French GPTS 8-item brief scale-8 retains the psychometric strengths of the R-GPTS in schizophrenia with relevant clinical validity. The GPTS-8 can consequently be used as a short and quick measure...

The reliability and validity of the revised Green et al. paranoid thoughts scale in individuals at clinical high-risk for psychosis.

Paranoia is a common and impairing psychosis symptom, which exists along a severity continuum that extends into the general population. Individuals at clinical high-risk for psychosis (CHR) frequently... Participants were CHR individuals (n = 103), mixed clinical controls (n = 80), and healthy controls (n = 71) who completed self-report and interview measures. Confirmatory factor analysis (CFA), psych... CFA replicated a two-factor structure for the RGPTS and the associated reference and persecution scales were reliable. CHR individuals scored significantly higher on both reference and persecution, re... These results demonstrate the reliability and validity of the RGPTS, though its scales related more weakly to severity in CHR individuals. The RGPTS may be useful in future work aiming to develop symp...

Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefs.

Cognitive Bias Modification for paranoia (CBM-pa) is a novel, theory-driven psychological intervention targeting the biased interpretation of emotional ambiguity associated with paranoia. Study object... In a double-blind randomised controlled trial, sixty-three outpatients with clinically significant paranoia were randomised to either CBM-pa or an active control (text reading) between April 2016 and ... A total of 122 patients were screened and 63 were randomised. The recruitment rate was 51.2%, with few dropouts (four out of 63) and follow-up rates were 90.5% (1-month) and 93.7% (3-months). Each ses... CBM-pa is feasible for patients with paranoia. A fully powered randomised control trial is warranted....